Join The Discussion

 

Ex Rangers manager Washington apologizes for 'breaking wife's trust'

IRVING, Texas (AP) — Former Texas Rangers manager Ron Washington says he is embarrassed for 'breaking his wife's trust.'

read more >

Troubled RadioShack files SEC form, talks with 'major vendor'

RadioShack Corp.’s latest filing with the U.S. Securities and Exchange Commission describes recent discussions that “could be beneficial to the financial restructuring of the company.”

read more >

Road Show: City leaders prepare campaign to corral votes for $450 million arena

Fort Worth’s biggest backers of a new arena at the Will Rogers Memorial Center are leaving little to the chance of a “no” vote in a citywide election Nov. 4 to decide on new fees that would fund 15 percent of the $450 million project.

read more >

Texas Health Southwest breaks ground on $40M expansion

A $40 million expansion of Texas Health Harris Methodist Hospital Southwest Fort Worth is under way, with groundbreaking ceremonies held this week.

read more >

Overland Sheepskin opening Sundance Square store in Fort Worth

The store is expected to open by the holidays, Sundance said.

read more >

TECH Fort Worth client receives $550,000 financing

 

Betty Dillard

bdillard@bizpress.net

Vital Art and Science Inc. (VAS), creator of the myVisionTrack home vision monitor, has completed a $550,000 Series A round of financing, the Richardson-based company announced Aug. 27.


The funding will enable VAS to continue development of its smart phone-based home monitor products and support its work with strategic partners to bring the myVisionTrack test to millions of patients around the world.
The funding round was led by the North Texas Angel Network (NTAN), and valued the company at $10 million post financing.


“The myVisionTrack home monitor is the first easy-to-use and accurate test for patients already diagnosed with a wet-AMD, or diabetic retinopathy, to monitor their disease progress and help ensure they get timely treatments to help save their vision,” said Mike Bartlett, VAS founder and president.


Bartlett said the company received its clearance from the U.S. Food and Drug Administration in February. The funding will allow VAS, a client of technology incubator TECH Fort Worth, to bring its product to market.
MyVisionTrack can be used in a physician’s office or at home by patients with these diseases to help track disease progression, detect disease condition changes for earlier intervention and document treatment effects.
 

< back

Email   email
hide
Arena
What do you think of the new plans for a new Will Rogers arena and changes at the Convention Center?